Physician

Parthiv S Mehta, M.D.

According to 2025 Medicare claims, Parthiv Mehta, M.D. (NPI: 1962539759) practices radiation oncology in the Chicago-Naperville-Schaumburg, IL market, with the plurality of this provider's patient population coming from Cook, IL. This provider's primary affiliated billing organization is UROPARTNERS LLC (NPI: 1073567905; TIN: 20-1780406) and primary practice location at 60026-8024.

Mehta's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 592 traditional Medicare patients, billed 30,248 HCPCS/CPT codes, and received $6,508,319 in Medicare payments. The top billing code was 77338 (Design and construction of radiation treatment device for high precision radiation therapy). Part D data shows 1,878 prescription claims across 526 beneficiaries totaling $3,442,255 in drug costs, led by Xtandi (Enzalutamide). Open Payments data shows 103 records totaling $33,579. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $23,319 to $3,442,255. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	532	27,447	$5,010,024
2016	617	26,144	$5,654,197
2017	680	30,331	$5,806,865
2018	592	28,542	$7,020,369
2019	463	30,553	$6,521,307
2020	449	27,399	$6,340,532
2021	387	24,430	$5,783,549
2022	436	23,665	$6,584,566
2023	496	26,772	$6,375,422
2024	592	30,248	$6,508,319

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	181	625	$23,319
2016	169	518	$78,030
2017	199	612	$153,940
2018	220	645	$165,102
2019	259	866	$28,510
2020	246	741	$298,469
2021	264	813	$481,014
2022	288	878	$1,296,376
2023	354	1,209	$1,848,061
2024	526	1,878	$3,442,255

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
77338	Design and construction of radiation treatment device for high precision radiation therapy	229	346	$380
77290	Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved	231	246	$345
77280	Obtaining data needed to develop the optimal radiation treatment, 1 treatment area	237	364	$216
77336	Continuing radiation therapy consultation per week	238	1,380	$73
36415	Insertion of needle into vein for collection of blood sample	416	1,244	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xtandi	Enzalutamide	167	5,010	$2,299,259
Orgovyx	Relugolix	268	8,262	$704,745
Erleada	Apalutamide	22	660	$338,702
Abiraterone Acetate	Abiraterone Acetate	77	2,370	$34,900
Tamsulosin Hcl	Tamsulosin Hcl	553	32,229	$9,436

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	103	$33,579	Boston Scientific Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Parthiv S. Mehta, M.D.?

Tedicare shows public-source Medicare data for Parthiv S. Mehta, M.D. (NPI 1962539759), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Parthiv S. Mehta, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Parthiv S. Mehta, M.D.?

Parthiv S. Mehta, M.D. is linked to UROPARTNERS LLC (billing NPI 1073567905) in the available physician profile data.

Does Parthiv S. Mehta, M.D. have Open Payments data?

Parthiv S. Mehta, M.D. has 103 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.